Kumar B. N. P., Puvvada N., Rajput S., Sarkar S., Mahto K., Yallapu M., Pathak A., Emdad L., Das S. K., Reis R. L., Kundu S. C., Fisher B., and Mandal M.,  "Targeting of EGFR, VEGFR2 and Akt by engineered dual drug encapsulated mesoporous silica-gold nanoclusters sensitizes tamoxifen-resistant breast cancer",  ACS Molecular Pharmaceutics, vol. 15, issue 7, pp. 2698?2713, doi:10.1021/acs.molpharmaceut.8b00218, 2018.